Antibody-drug Conjugates in the Clinic: Key Considerations & the Role of Modeling in Expediting Development
Antibody-Drug Conjugates (ADCs) can be an ideal drug treatment for cancer because they deliver a…
Certara2023年4月17日
Stepwise PIPs: A Solution for the Challenges of Pediatric Drug Development
Early paediatric investigation plan (PIP) submissions – an unnecessarily bitter medicine? In the European Union…
Certara2023年4月14日
Why Performing Key CMC Activities Early Can Aid De-risking Your Drug Development Program
This white paper focuses on best practices for developing a CMC strategy for orally administered…
Certara2023年4月13日
Drug Discovery & Development with Deep Learning Advanced Analytics
Solutions to Meet All Needs: From Small Biotech to Large Global Pharma
Certara2023年4月6日
Considerations for Pricing & Formulary Access for DRG-Funded Hospital Drugs
In the United States, treatments or medical services that require the patient be admitted into…
Certara2023年4月6日
Using Quantitative Systems Pharmacology Modelling to Accelerate Drug Development
Model informed drug development (in silico modelling) continues to be a game changer in accelerating…
Certara2023年3月29日
Model-Informed Drug Development (MIDD) – EMA’s Advancement
Modelling and simulation (M&S) plays a crucial role in drug development. It allows information from…
Certara2023年3月29日
Advancing Biopharmaceutics & Drug Formulation Using In Silico Modeling
モデルを活かした製剤開発（MIFD）は、新薬およびジェネリック医薬品の開発を迅速化し、確実性を高めます。
Certara2023年3月22日
